Last Updated on Nov 13, 2026

Clinical Advances in Hematology and Oncology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Millennium Medical Publishing, Inc.

Abbreviation: Clin. Adv. Hematol. Oncol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

0.47

SJR

 

h-Index

 47

Rank

 17829

Important Details

Title Clinical Advances in Hematology and Oncology
Standard Abbreviation Clin. Adv. Hematol. Oncol.
Type of Publication Journal
Discipline Hematology (Q3); Medicine (miscellaneous) (Q3); Oncology (Q3)
Impact Score 0.47
SCImago Journal Rank (SJR)
h-index 47
Overall Rank 17829
Publisher Name Millennium Medical Publishing, Inc.
Publication Country United States
International Standard Serial Number (ISSN) 15430790
Coverage and History 2003-2026
Best Quartile Q3
Total Citations Received
(Last 3 Year)
124

About Clinical Advances in Hematology and Oncology


Clinical Advances in Hematology and Oncology is a journal published by Millennium Medical Publishing, Inc.. This journal covers the area[s] related to Hematology, Medicine (miscellaneous), Oncology, etc. The coverage history of this journal is as follows: 2003-2026. The rank of this journal is 17829. This journal's impact score, h-index, and SJR are 0.47, 47, and , respectively. The ISSN of this journal is/are as follows: 15430790.

The best quartile of Clinical Advances in Hematology and Oncology is Q3. This journal has received a total of 124 citations during the last three years (Preceding 2025).


Clinical Advances in Hematology and Oncology Impact Score 2025-2026


The latest impact score (IS) of the Clinical Advances in Hematology and Oncology is 0.47. It is computed in the year 2026 as per its definition and based on Scopus data. 0.47

It is increased by a factor of around 0.01, and the percentage change is 2.17% compared to the preceding year 2024, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Clinical Advances in Hematology and Oncology Impact Score 2026


Impact Score 2025 of Clinical Advances in Hematology and Oncology is 0.47. If a similar upward trend continues, IS may increase in 2026 as well.


Impact Score Graph


Check below the Impact Score trends of Clinical Advances in Hematology and Oncology. This is based on Scopus data.


Year Impact Score (IS)
2026/2027 Coming Soon
2025 0.47
2024 0.46
2023 0.42
2022 0.41
2021 0.52
2020 0.69
2019 0.49
2018 0.63
2017 0.62
2016 0.57
2015 0.55
2014 0.45

Clinical Advances in Hematology and Oncology h-index


  Table Setting

The h-index of Clinical Advances in Hematology and Oncology is 47. By definition of the h-index, this journal has at least 47 published articles with more than 47 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Clinical Advances in Hematology and Oncology ISSN


The International Standard Serial Number (ISSN) of Clinical Advances in Hematology and Oncology is/are as follows: 15430790.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Clinical Advances in Hematology and Oncology Ranking and SCImago Journal Rank (SJR)


The Clinical Advances in Hematology and Oncology is ranked 17829 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked .

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Clinical Advances in Hematology and Oncology Publisher


Table Setting

The publisher of Clinical Advances in Hematology and Oncology is Millennium Medical Publishing, Inc.. The publishing house of this journal is located in the United States. Its coverage history is as follows: 2003-2026.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Clinical Advances in Hematology and Oncology is Clin. Adv. Hematol. Oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Clin. Adv. Hematol. Oncol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Clinical Advances in Hematology and Oncology


If your area of research or discipline is related to Hematology, Medicine (miscellaneous), Oncology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Clinical Advances in Hematology and Oncology?

The latest impact score of Clinical Advances in Hematology and Oncology is 0.47. It is computed in the year 2026.


What is the h-index of Clinical Advances in Hematology and Oncology?

The latest h-index of Clinical Advances in Hematology and Oncology is 47. It is evaluated in the year 2026.


What is the SCImago Journal Rank (SJR) of Clinical Advances in Hematology and Oncology?

The latest SCImago Journal Rank (SJR) of Clinical Advances in Hematology and Oncology is . It is calculated in the year 2026.


What is the ranking of Clinical Advances in Hematology and Oncology?

The latest ranking of Clinical Advances in Hematology and Oncology is 17829. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2026.


Who is the publisher of Clinical Advances in Hematology and Oncology?

Clinical Advances in Hematology and Oncology is published by Millennium Medical Publishing, Inc.. The publication country of this journal is United States.


What is the abbreviation of Clinical Advances in Hematology and Oncology?

This standard abbreviation of Clinical Advances in Hematology and Oncology is Clin. Adv. Hematol. Oncol..


Is "Clinical Advances in Hematology and Oncology" a Journal, Conference or Book Series?

Clinical Advances in Hematology and Oncology is a journal published by Millennium Medical Publishing, Inc..


What is the scope of Clinical Advances in Hematology and Oncology?

The scope of Clinical Advances in Hematology and Oncology is as follows:

  • Hematology
  • Medicine (miscellaneous)
  • Oncology

For detailed scope of Clinical Advances in Hematology and Oncology, check the official website of this journal.


What is the ISSN of Clinical Advances in Hematology and Oncology?

The International Standard Serial Number (ISSN) of Clinical Advances in Hematology and Oncology is/are as follows: 15430790.


What is the best quartile for Clinical Advances in Hematology and Oncology?

The best quartile for Clinical Advances in Hematology and Oncology is Q3.


What is the coverage history of Clinical Advances in Hematology and Oncology?

The coverage history of Clinical Advances in Hematology and Oncology is as follows 2003-2026.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
European Union Politics Journal SAGE Publications Ltd 2915 83 3.16
Proceedings of the ASME Turbo Expo Conference And Proceedings 17577 54 0.00
Qualitative Research Journal SAGE Publications Ltd 1492 109 5.46
IEEE/OSA Journal of Display Technology Journal IEEE Computer Society 12809 68 0.00
Journal of Applied Business Research Journal Clute Institute 26260 33 0.17
Archives of Phytopathology and Plant Protection Journal Taylor and Francis Ltd. 17163 38 1.51
World Englishes Journal John Wiley and Sons Inc 6582 72 2.23
International Conference on Architectural Support for Programming Languages and Operating Systems - ASPLOS Conference And Proceedings Association for Computing Machinery 1030 120 10.08
Exploration Geophysics Journal Taylor and Francis Ltd. 21265 54 0.74
Indian Phytopathology Journal Springer 17628 24 1.16

Check complete list




Clinical Advances in Hematology and Oncology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2026/2027 Updated Soon
2025 0.47
2024 0.46
2023 0.42
2022 0.41
2021 0.52
2020 0.69
2019 0.49
2018 0.63
2017 0.62
2016 0.57
2015 0.55
2014 0.45



Top Journals/Conferences in Hematology

BMC Hematology
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

See All

Top Journals/Conferences in Medicine (miscellaneous)

Wiley Interdisciplinary Reviews: Systems Biology and Medicine
John Wiley & Sons Inc. | United States

MicroRNA (Shariqah, United Arab Emirates)
Bentham Science Publishers B.V. | United Arab Emirates

Alcoholism: Clinical and Experimental Research
Wiley-Blackwell | United States

ADHD Attention Deficit and Hyperactivity Disorders
Springer-Verlag Wien | Austria

Clinical Research in Cardiology Supplements
Springer Verlag | Germany

Rural policy brief
Rural Policy Research Institute | United States

Female Pelvic Medicine and Reconstructive Surgery
Lippincott Williams and Wilkins Ltd. | United States

Journal of studies on alcohol and drugs. Supplement
Alcohol Research Documentation, Inc. | United States

Journal of investigative and clinical dentistry
Wiley-Blackwell | United States

Global Advances In Health and Medicine
SAGE Publications Inc. | United States

Progress in molecular and subcellular biology
Springer Verlag | Germany

Seminars in Cutaneous Medicine and Surgery
Frontline Medical Communications Inc. | United States

Progress in the chemistry of organic natural products
Springer Verlag | Germany

Hospital practice (1995)
Taylor and Francis Ltd. | United Kingdom

Experientia supplementum (2012)
Springer International Publishing AG | Switzerland

See All

Top Journals/Conferences in Oncology

Cancer Microenvironment
Springer Netherlands | Netherlands

Current Colorectal Cancer Reports
Springer Science + Business Media | United States

Australian Journal of Cancer Nursing
Cambridge Media | Australia

Clinical Sarcoma Research
BioMed Central Ltd. | United Kingdom

Onkologe
Springer Verlag | Germany

Onkopediatria
Paediatrician Publishers, LLC | Russian Federation

See All